Meaningful positive changes in Resmed Inc (NYSE: RMD) fundamentals have recently occurred: the consensus estimate for June, 2024 increased significantly, the stock’s power rating rose above 70, and the consensus estimate for June, 2025 increased significantly.
Resmed Inc (NYSE: RMD). Significant positive changes in investment behavior have recently occurred: its longer term price trend turned up.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, RMD is expected to continue to be a modest Value Builder.
Resmed has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Resmed has a very low Appreciation Score of 10 but a good Power Rating of 77, leading to the Low Neutral Value Trend Rating.
Recent Price Action
Resmed Inc (NYSE: RMD) stock increased 1.9% on 5/13/24. The shares closed at $217.89. However, below average trading volume at 67% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and is unchanged during the last week.
Be the first to comment